Latest Breaking News On - Pediatric nephrology - Page 6 : comparemela.com

A valuable home dialysis procedure for children with chronic kidney disease

A valuable home dialysis procedure for children with chronic kidney disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesLavjay butaniMaha haddadMark josephOregon health science universityUc davis healthPediatric nephrologyOregon healthScience university

Those with kidney failure due to sickle cell disease wait longer for transplants, have higher mortality

Those with kidney failure due to sickle cell disease wait longer for transplants, have higher mortality
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesRima zahrLe bonheurRimas zahrAmerican society of hematologyUnited states renal data systemAmerican societyPediatric nephrology

Travere Therapeutics Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM Respectively and Presented at the American Society of Nephrology (ASN) Kidney Week 2023

Two-year results from both PROTECT and DUPLEX pivotal Phase 3 studies demonstrate treatment with sparsentan has the potential to preserve kidney function and significantly delay time to kidney.

United statesMichellen rheaultBrad rovinNivi nehraNaomi eichenbaumJula inrigOhio state university centerDivision for nephrologyTravere therapeutics incAmerican society of nephrologyDivision of pediatric nephrologyExchange commissionCorporate communicationsClinical research managementUniversity of minnesota medical schoolAmerican society

Travere Therapeutics (TVTX) Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM

Travere Therapeutics (TVTX) Announces Late-Breaking Data from Phase 3 Studies of Sparsentan in IgAN and FSGS Published in The Lancet and The NEJM
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBrad rovinJula inrigMichellen rheaultDivision of pediatric nephrologyTravere therapeutics incOhio state university centerDivision for nephrologyUniversity of minnesota medical schoolAmerican society of nephrologyClinical research managementTravere therapeuticsAmerican societyKidney weekNew england journalMedical director

Sparsentan Use Could Lower Risk of Kidney Failure, Death in FSGS

Although the DUPLEX trial missed its primary endpoint of eGFR slope in patients with FSGS, results point to greater reductions in proteinuria and in risk of kidney failure with sparsentan use relative to irbesartan making its case for becoming a standard of care for the glomerular disease.

United statesMichelle rheaultJulier ingelfingerUniversity of minnesota michelle rheaultAmerican society of nephrology kidney weekUniversity of minnesotaAmerican societyNephrology kidney weekTravere therapeuticsNew england journalPediatric nephrologyMassachusetts general hospitalFocal segmentalAsn 23Kidney weekFsgs treatments